The goal of this study is to develop and pilot test a multi-communication approach to improve informed decision-making about cancer Clinical Trials (CTs) participation by increasing awareness of CTs and Mays Cancer Center (MCC) services (treatment care capacities, reputation and resources), positive attitudes towards CTs, self-efficacy and intentions to consider CTs as an appropriate treatment option for cancer (intention to participate) among patients attending the MCC (clinic-based setting) and the general public in selected Bexar County areas (community-based settings).
Patricia Chalela
+1 (210) 562-6513
chalela@uthscsa.edu
Vivian Cortez
(210) 567-6528
cortezv1@uthscsa.edu
Anna Moreno
(210) 567-0836
morenoa3@uthscsa.edu
Principal Investigator
Amelie Ramirez
Patricia Chalela
+1 (210) 562-6513
chalela@uthscsa.edu
Vivian Cortez
(210) 567-6528
cortezv1@uthscsa.edu
Anna Moreno
(210) 567-0836
morenoa3@uthscsa.edu
Amelie Ramirez
(210) 562-6500
ramirezag@uthscsa.edu
Arm | Description | Intervention |
---|---|---|
Usual Care Control Group | Participants in the usual care control group will receive a general clinical trial fact sheet. | General Clinical Trial fact sheet with usual care information regarding Clinical Trials. |
Intervention Group | Participants in the intervention group will receive 3 components: 1) a culturally tailored clinical trial educational video, 2) a brochure and 3) support from a patient navigator to empower new cancer patients to make informed decisions about cancer clinical trials by increasing awareness of clinical trials and MCC services, positive attitudes and intentions to consider clinical trials as an appropriate treatment option for cancer. | Culturally tailored educational video, brochure, and support from a patient navigator to empower new cancer patients to make informed decisions about cancer clinical trials. A brochure with educational material about clinical trials and services offered by Mays Cancer Center. Support that will be provided by a patient navigator to empower new cancer patients to make an informed decision about cancer clinical trials by increasing awareness of clinical trials and MCC services, positive attitudes and intentions to consider clinical trials as an appropriate treatment option. |